ALS biomarkers are lowered with Coya’s Treg therapy: Study
Treatment with regulatory T-cells (Tregs), a type of anti-inflammatory immune cell, reduced biomarker levels of inflammation and oxidative stress…
Articles by Steve Bryson, PhD
Survival in sporadic ALS linked to autophagy protein p62
Increased accumulation of p62, a protein involved in a cellular recycling process called autophagy, in the spinal cord is associated…
Neurologists frustrated with ALS treatments now on market: Study
While neurologists are frustrated with the treatments for amyotrophic lateral sclerosis (ALS) now on the market, they rapidly adopt…
MTPA to stop Phase 3 trial of approved Radicava ORS for ALS
Mitsubishi Tanabe Pharma America (MTPA), which had been testing a once-daily regimen of its oral therapy Radicava ORS…
Asthma medicine slows ALS disease progression in small trial
Six months of treatment with clenbuterol, an asthma medication, slowed disease progression in adults with amyotrophic lateral sclerosis (ALS),…
CNM-Au8 slows disease progression and extends life, RESCUE-ALS finds
CNM-Au8 extended long-term survival and slowed disease progression in adults with early stage amyotrophic lateral sclerosis (ALS) compared…
QurAlis teaming with Unlearn to use AI to improve ALS clinical trials
The technology company Unlearn has joined with QurAlis to use artificial intelligence (AI) to speed up clinincal trials…
EMA branch opposes conditional approval of AMX0035 in Europe
The Committee for Medicinal Products for Human Use (CHMP) has issued an opinion opposing Amylyx Pharmaceuticals’ bid for…
Magnetic stimulation seen to restore ALS motor neurons in cell study
Magnetic stimulation restored the health of lab-grown motor neurons — the muscle-controlling nerve cells that die in amyotrophic lateral…
Virus-like protein needed for healthy placenta also may promote ALS
PEG10, an ancient, virus-like protein that supports the development of the placenta, appears to also participate in the nerve cell…